{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:06:44Z","timestamp":1789646804615,"version":"4.0.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jada.ada.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of the American Dental Association"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.adaj.2024.03.001","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T03:11:05Z","timestamp":1714533065000},"page":"561-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Orally dissolving buprenorphine for opioid use disorder linked to caries"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2303-0603","authenticated-orcid":false,"given":"Stuart L.","family":"Segelnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mea A.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adaj.2024.03.001_bib1","author":"Azadfard"},{"key":"10.1016\/j.adaj.2024.03.001_bib2","author":"Dydyk"},{"key":"10.1016\/j.adaj.2024.03.001_bib3","series-title":"Drug overdose deaths","year":"2023"},{"issue":"8","key":"10.1016\/j.adaj.2024.03.001_bib4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamapsychiatry.2018.0611","article-title":"Making the opioid public health emergency effective","volume":"75","author":"Haffajee","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.adaj.2024.03.001_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1046648","article-title":"Suboxone: history, controversy, and open questions","volume":"13","author":"Sivils","year":"2022","journal-title":"Front Psychiatry"},{"issue":"8","key":"10.1016\/j.adaj.2024.03.001_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.adaj.2024.03.001_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13054-020-2740-y","article-title":"Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial","volume":"24","author":"Zamani","year":"2020","journal-title":"Crit Care"},{"issue":"suppl 1","key":"10.1016\/j.adaj.2024.03.001_bib8","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.1191\/0269216306pm1126oa","article-title":"Opioid-induced respiratory effects: new data on buprenorphine","volume":"20","author":"Dahan","year":"2006","journal-title":"Palliat Med"},{"issue":"1","key":"10.1016\/j.adaj.2024.03.001_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan","year":"2012","journal-title":"Br J Pain"},{"issue":"4","key":"10.1016\/j.adaj.2024.03.001_bib10","first-page":"445","article-title":"Brain mechanisms of drug reward and euphoria","volume":"3","author":"Wise","year":"1985","journal-title":"Psychiatr Med"},{"key":"10.1016\/j.adaj.2024.03.001_bib11","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fpsyt.2019.00592","article-title":"Craving in opioid use disorder: from neurobiology to clinical practice","volume":"10","author":"Kakko","year":"2019","journal-title":"Front Psychiatry"},{"issue":"6","key":"10.1016\/j.adaj.2024.03.001_bib12","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/j.bja.2019.03.006","article-title":"Hot topics in opioid pharmacology: mixed and biased opioids","volume":"122","author":"Azzam","year":"2019","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.adaj.2024.03.001_bib13","first-page":"241","article-title":"Adverse effects of opioid analgesics from the central nervous system","volume":"15","author":"Wojtasik-Bakalarz","year":"2021","journal-title":"Palliat Med Pract"},{"key":"10.1016\/j.adaj.2024.03.001_bib14","author":"Fudin"},{"issue":"1","key":"10.1016\/j.adaj.2024.03.001_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review","volume":"4","author":"Yokell","year":"2001","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.adaj.2024.03.001_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2022.107589","article-title":"Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: a systematic review of randomized controlled trials","volume":"139","author":"Baxley","year":"2023","journal-title":"Addict Behav"},{"issue":"4","key":"10.1016\/j.adaj.2024.03.001_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"10.1016\/j.adaj.2024.03.001_bib20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/biom11060816","article-title":"Buprenorphine: far beyond the \u201cceiling.\u201d","volume":"11","author":"Infantino","year":"2021","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.adaj.2024.03.001_bib22","doi-asserted-by":"crossref","DOI":"10.52965\/001c.37517","article-title":"Buprenorphine and its formulations: a comprehensive review","volume":"10","author":"Poliwoda","year":"2022","journal-title":"Health Psychol Res"},{"key":"10.1016\/j.adaj.2024.03.001_bib23","article-title":"Drug Safety Communication: FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain","year":"2022","journal-title":"US Food and Drug Administration"},{"key":"10.1016\/j.adaj.2024.03.001_bib24","author":"Urzen"},{"key":"10.1016\/j.adaj.2024.03.001_bib25","author":"Brooks"},{"issue":"22","key":"10.1016\/j.adaj.2024.03.001_bib27","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/jama.2022.17485","article-title":"Association between sublingual buprenorphine-naloxone exposure and dental disease","volume":"328","author":"Etminan","year":"2022","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.adaj.2024.03.001_bib28","first-page":"929","article-title":"Oral health of drug abusers: a review of health effects and care","volume":"42","author":"Shekarchizadeh","year":"2013","journal-title":"Iran J Public Health"},{"issue":"5","key":"10.1016\/j.adaj.2024.03.001_bib29","article-title":"Sublingual buprenorphine and dental problems: a case series","volume":"l15","author":"Suzuki","year":"2013","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.adaj.2024.03.001_bib30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/add.13754","article-title":"A\u00a0systematic review and meta-analysis of the association between poor oral health and substance abuse","volume":"112","author":"Baghaie","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.adaj.2024.03.001_bib31","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1111\/add.15360","article-title":"Illicit drug use and oral health","volume":"116","author":"Rossow","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.adaj.2024.03.001_bib32","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1186\/s12903-020-1010-3","article-title":"Dental caries and periodontal disease among people who use drugs: a systematic review and meta-analysis","volume":"20","author":"Yazdanian","year":"2020","journal-title":"BMC Oral Health"},{"issue":"11","key":"10.1016\/j.adaj.2024.03.001_bib33","first-page":"722","article-title":"What is the critical pH and why does a tooth dissolve in acid?","volume":"69","author":"Dawes","year":"2003","journal-title":"J\u00a0Can Dent Assoc"},{"key":"10.1016\/j.adaj.2024.03.001_bib34","series-title":"Wang co-investigating high oral exposure to buprenorphine on dental caries","author":"Rogers","year":"2023"},{"key":"10.1016\/j.adaj.2024.03.001_bib37","author":"Milgram"}],"container-title":["The Journal of the American Dental Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817724001296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817724001296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T01:18:07Z","timestamp":1733447887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002817724001296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0002817724001296"],"URL":"https:\/\/doi.org\/10.1016\/j.adaj.2024.03.001","relation":{},"ISSN":["0002-8177"],"issn-type":[{"value":"0002-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orally dissolving buprenorphine for opioid use disorder linked to caries","name":"articletitle","label":"Article Title"},{"value":"The Journal of the American Dental Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adaj.2024.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Dental Association. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}